☆ 4.7 Article

Similar Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Similar Nucleocapsid Antibody Levels in People With Well-Controlled Human Immunodeficiency Virus (HIV) and a Comparable Cohort of People Without HIV

JOURNAL OF INFECTIOUS DISEASES (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Health Care Sciences & Services

Differences in SARS-CoV-2 infections during the first and second wave of SARS-CoV-2 between six ethnic groups in Amsterdam, the Netherlands: A population-based longitudinal serological study

Liza Coyer et al.

Summary: This study investigated the cumulative incidence of SARS-CoV-2 and its determinants in six ethnic groups in Amsterdam. The study found that the cumulative incidence of SARS-CoV-2 was higher in South-Asian Surinamese, African Surinamese, Turkish, Moroccan, and Ghanaian participants compared to Dutch-origin participants.

LANCET REGIONAL HEALTH-EUROPE (2022)

添加到收藏夹

Article Immunology

Epidemiological, Virological and Serological Features of Coronavirus Disease 2019 (COVID-19) Cases in People Living With Human Immunodeficiency Virus in Wuhan: A Population-based Cohort Study

Jiao Huang et al.

Summary: This study aimed to describe the epidemiological, virological, and serological features of COVID-19 cases among people living with HIV. The incidence, case-severity, and case-fatality rates of COVID-19 in PLWH were comparable to those in the entire population in Wuhan. Efforts are needed to continue antiretroviral treatment for elderly PLWH aged 50 years or above during the COVID-19 epidemic.

CLINICAL INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Immunology

Outcomes of Coronavirus Disease 2019 (COVID-19) Related Hospitalization Among People With Human Immunodeficiency Virus (HIV) in the ISARIC World Health Organization (WHO) Clinical Characterization Protocol (UK): A Prospective Observational Study

Anna Maria Geretti et al.

Summary: This study compared the characteristics and outcomes of COVID-19 patients with and without HIV in the UK, finding that HIV-positive individuals had a higher risk of mortality, especially in those under 60 years old. Despite similar cumulative day-28 mortality rates, HIV-positive status was associated with increased mortality after adjusting for age and other variables.

CLINICAL INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Immunology

Coronavirus Disease 2019 (COVID-19) Infection Among People With Human Immunodeficiency Virus in New York City: A Population-Level Analysis of Linked Surveillance Data

Sarah L. Braunstein et al.

Summary: New York City, hard-hit by the SARS-CoV-2 pandemic, matched laboratory-confirmed COVID-19 cases with HIV patients, finding that while the HIV prevalence among COVID-19 cases wasn't overrepresented, HIV patients experienced worse COVID-19 outcomes due to factors associated with poor outcomes. This highlights the need to strengthen services and support for HIV patients in the face of health inequities exacerbated by the pandemic.

CLINICAL INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Immunology

SARS-CoV-2 Antibody Responses Are Correlated to Disease Severity in COVID-19 Convalescent Individuals

Cecilie Bo Hansen et al.

Summary: Novel ELISA-based assays for specific detection of human SARS-CoV-2 Abs were developed in this study, showing significant correlations between antibody responses and disease severity in COVID-19 patients. These assays and data contribute to diagnostics, prognosis, and understanding of long-term immunity.

JOURNAL OF IMMUNOLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

Jennifer M. Dan et al.

Summary: Different components of immune memory to SARS-CoV-2 exhibit distinct kinetics, with antibodies and spike-specific memory B cells remaining relatively stable over 6 months, while CD4(+) T cells and CD8(+) T cells declining with a half-life of 3 to 5 months after infection.

SCIENCE (2021)

添加到收藏夹

Article Medicine, General & Internal

Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020

Kristina L. Bajema et al.

Summary: This cross-sectional study indicates that as of September 2020, most people in the US did not have serologic evidence of previous SARS-CoV-2 infection, although the prevalence varied widely by jurisdiction. Seroprevalence surveys showed variations in infection rates between different sexes, age groups, and metropolitan/nonmetropolitan areas.

JAMA INTERNAL MEDICINE (2021)

添加到收藏夹

Article Immunology

Persistence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 in Relation to Symptoms in a Nationwide Prospective Study

Gerco den Hartog et al.

Summary: The study found that specific IgG antibodies against SARS-CoV-2 persist in 92% of participants after 7 months, while IgM and IgA antibodies declined rapidly after the first month. Those with significant symptoms maintained more stable antibody concentrations and higher IgG binding strength compared to asymptomatic individuals or those with mild upper respiratory complaints.

CLINICAL INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV

Aljawharah Alrubayyi et al.

Summary: The majority of people living with HIV on ART have detectable adaptive immune responses to SARS-CoV-2, with comparable humoral and T cell responses to HIV-negative subjects. T cell responses against Spike, Membrane and Nucleoprotein are prominent in both groups, with CD4 T cells outnumbering CD8 T cells. The magnitude of SARS-CoV-2-specific T cell responses is related to the size of the naive CD4 T cell pool and the CD4:CD8 ratio in people living with HIV, potentially impacting vaccine effectiveness and individual management.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Article Immunology

Disease Severity, Fever, Age, and Sex Correlate With SARS-CoV-2 Neutralizing Antibody Responses

Stephan Schlickeiser et al.

Summary: Clinical trials on the use of COVID-19 convalescent plasma have shown inconclusive results, with some patients potentially benefiting from the treatment of convalescent plasma neutralizing antibodies. Studies suggest that COVID-19 patients requiring hospitalization and experiencing fever symptoms may have higher risk of having lower levels of neutralizing antibodies.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

COVID-19 Outcomes Among Persons Living With or Without Diagnosed HIV Infection in New York State

James M. Tesoriero et al.

Summary: This cohort study conducted in New York State found that persons living with diagnosed HIV had poorer outcomes related to COVID-19 compared to persons living without diagnosed HIV. Previous HIV diagnosis was associated with higher rates of severe disease requiring hospitalization, and hospitalization risk increased with progression of HIV disease stage.

JAMA NETWORK OPEN (2021)

添加到收藏夹

Article Immunology

Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study

Daniel K. Nomah et al.

Summary: This study assessed factors associated with SARS-CoV-2 diagnosis and severe outcomes among people living with HIV. The findings showed that age, immigrant status, sexual orientation, chronic comorbidities, and other factors were associated with SARS-CoV-2 diagnosis and severe outcomes. Participants with detectable HIV viraemia, chronic comorbidities, and certain subpopulations were at increased risk of severe outcomes from COVID-19, highlighting the importance of prioritizing these groups in clinical management and vaccination programs.

LANCET HIV (2021)

添加到收藏夹

Article Immunology

Associations between HIV infection and clinical spectrum of COVID-19: a population level analysis based on US National COVID Cohort Collaborative (N3C) data

Xueying Yang et al.

Summary: The study using N3C data in the US found that individuals with HIV infection have higher odds of COVID-19 death and hospitalisation, but lower odds of mild or moderate COVID-19. Factors such as older age, male gender, and specific racial/ethnic groups may exacerbate the risk of adverse COVID-19 outcomes among people with HIV.

LANCET HIV (2021)

添加到收藏夹

Article Medicine, General & Internal

Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study

Zhenyu He et al.

LANCET (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2

Joseph E. Ebinger et al.

Summary: Virus-specific antibody levels after a single dose of the BNT162b2 vaccine in individuals previously infected with SARS-CoV-2 are similar to levels after two doses of the vaccine in infection-naive individuals. Post-vaccine symptoms were more prominent for those with prior infection after the first dose, but symptomology was similar between groups after the second dose.

NATURE MEDICINE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Epidemiology and outcomes of COVID-19 in HIV-infected individuals: a systematic review and meta-analysis

Paddy Ssentongo et al.

Summary: Susceptibility to SARS-CoV-2 infection and mortality risk are higher among people living with HIV/AIDS compared to HIV-negative individuals. The beneficial effects of antiretroviral therapy in reducing infection and mortality risks for COVID-19 in PLWHA remain inconclusive. Prioritizing SARS-CoV-2 vaccination for persons with HIV is recommended to mitigate the increased risk associated with HIV infection.

SCIENTIFIC REPORTS (2021)

添加到收藏夹

Article Immunology

SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study

Matthew Spinelli et al.

Summary: This study compared the SARS-CoV-2 infection rate, disease severity, and immune response between people living with HIV and those without HIV. The findings showed that although fewer infections were detected among people with HIV, they had more severe cases of COVID-19. Lower IgG concentrations and neutralising antibody titres in HIV-positive individuals suggest a diminished immune response to the infection.

LANCET HIV (2021)

添加到收藏夹

Article Infectious Diseases

Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network Cohort

Juan Berenguer et al.

Summary: The study found a SARS-CoV-2 antibody detection rate of 8.5% among people with HIV, with 45% of infections being asymptomatic. Birth in Latin American countries increased the likelihood of SARS-CoV-2 antibody positivity. Therapy with tenofovir disoproxil fumarate plus emtricitabine (TDF/FTC) may help prevent SARS-CoV-2 infection among PWH.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

添加到收藏夹

Article Infectious Diseases

SARS-CoV-2 infection and mortality during the first epidemic wave in Madurai, south India: a prospective, active surveillance study

Ramanan Laxminarayan et al.

Summary: A large-scale SARS-CoV-2 surveillance programme in Madurai, India revealed equal risk of asymptomatic infection among children, teenagers, and working-age adults, with increasing risk of infection and death associated with older age and comorbidities.

LANCET INFECTIOUS DISEASES (2021)

添加到收藏夹

Letter Medicine, General & Internal

Durable Humoral and Cellular Immune Responses 8 Months after Ad26.COV2.S Vaccination

Dan H. Barouch et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

SARS-CoV-2 percent positivity and risk factors among people with HIV at an urban academic medical center

Eleanor E. Friedman et al.

Summary: Despite being more likely to be in higher-risk demographic groups, individuals with HIV were not found to have a higher likelihood of testing positive for SARS-CoV-2 in this study. The only significant differences seen between HIV-positive individuals who tested positive versus negative for SARS-CoV-2 were related to Hispanic/Latino ethnicity and the testing location.

PLOS ONE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

SARS-CoV-2 antibody dynamics and transmission from community-wide serological testing in the Italian municipality of Vo'

Ilaria Dorigatti et al.

Summary: A study in Vo', Italy, conducted two mass swab testing campaigns in February and March 2020, followed by serological surveys in May and November. The findings show a seroprevalence of 3.5% in May and indicate that the majority of positive sera in May still reacted against at least one antigen in November. Analysis of household members revealed a Susceptible-Infectious Transmission Probability of 26.0%, with limited impact of contact tracing on epidemic suppression.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Article Immunology

The first 12 months of COVID-19: a timeline of immunological insights

Thiago Carvalho et al.

Summary: The timeline of major scientific discoveries during the first year of the COVID-19 pandemic highlights the collaborative efforts that led to rapid progress in understanding the immune response to SARS-CoV-2. It showcases the unprecedented convergence of research efforts on COVID-19 and identifies gaps in knowledge for future investigations.

NATURE REVIEWS IMMUNOLOGY (2021)

添加到收藏夹

Review Immunology

The interplay between HIV and COVID-19: summary of the data and responses to date

Lillian B. Brown et al.

Summary: Current evidence does not suggest that people living with HIV are at significantly higher risk of contracting SARS-CoV-2, but the prevalence of comorbidities associated with COVID-19 severity among PLWH remains a pressing issue. The COVID-19 epidemic has led to decreased access to HIV prevention services and testing, as well as worsened HIV treatment access and virologic control, potentially exacerbating the HIV epidemic.

CURRENT OPINION IN HIV AND AIDS (2021)

添加到收藏夹

Article Infectious Diseases

Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study

Simon de Lusignan et al.

LANCET INFECTIOUS DISEASES (2020)

添加到收藏夹

Article Immunology

Clinical characteristics, risk factors, and incidence of symptomatic coronavirus disease 2019 in a large cohort of adults living with HIV: a single-center, prospective observational study

Alexy Inciarte et al.

AIDS (2020)

添加到收藏夹

Article Immunology

Characteristics and outcomes of COVID-19 in patients with HIV: a multicentre research network study

Yousaf B. Hadi et al.

AIDS (2020)

添加到收藏夹

Article Medicine, General & Internal

Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy A Cohort Study

Julia del Amo et al.

ANNALS OF INTERNAL MEDICINE (2020)

添加到收藏夹

Article Infectious Diseases

Two serological approaches for detection of antibodies to SARS-CoV-2 in different scenarios: a screening tool and a point-of-care test

Alexis C. R. Hoste et al.

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2020)

添加到收藏夹

Article Medicine, General & Internal

Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study

Marina Pollan et al.

LANCET (2020)

添加到收藏夹

Article Medicine, General & Internal

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Pedro M. Folegatti et al.

LANCET (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity

Carolyn Rydyznski Moderbacher et al.

CELL (2020)

添加到收藏夹

Article Medicine, General & Internal

An mRNA Vaccine against SARS-CoV-2-Preliminary Report

L. A. Jackson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Medicine, General & Internal

Humoral Immune Response to SARS-CoV-2 in Iceland

Daniel F. Gudbjartsson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19

Xiangyu Chen et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

添加到收藏夹

Article Medical Informatics

Assessing risk factors for SARS-CoV-2 infection in patients presenting with symptoms in Shanghai, China: a multicentre, observational cohort study

Bei Mao et al.

LANCET DIGITAL HEALTH (2020)

添加到收藏夹

Article Immunology

Cross-sectional Comparison of the Prevalence of Age-Associated Comorbidities and Their Risk Factors Between HIV-Infected and Uninfected Individuals: The AGEhIV Cohort Study

Judith Schouten et al.

CLINICAL INFECTIOUS DISEASES (2014)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.